Nasdaq

Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs

Basel, 17 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three ...
News Medical

Roche Diagnostics introduces STAT immunoassays for cardiac biomarker testing

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas® 6000 analyzer series, an ...
WRBL

Roche granted FDA clearance for cobas pure integrated solutions for low- to mid-volume laboratories

INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, ...
FierceBiotech

Roche to bring mass spec to routine labs with new cobas system’s European approval

Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to the everyday clinical lab. The company received a CE Mark approval in Europe ...
Nasdaq

Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories

The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care. The new cobas c 703 ...
News Medical

Roche granted FDA 510(k) clearance for cobas 8000 modular analyzer series

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum ...